BD Venture
VC Fund
Dhaka, Bangladesh
BD Venture is a VC fund in Dhaka focused on Medical and Health Care. BD Venture Limited, a Venture Capital Company, is an outcome of relentless effort from a group of leaders of the financial and entrepreneurial ecosystems of Bangladesh with a view to promoting innovative and potential seed, early & growth stage entrepreneurs & enterprises to pave their expansion through facilitating investment, consultancy& other relevant services. We are capable to address and accommodate the undulations of a venture and tailor our & the investee enterprise’s shape to adapt with a perspective approach. We have adopted innovative ways of investment for those entrepreneurs or enterprises for who the doors of the conventional financing institutions are hardly open.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries BD Venture invests in
Stages BD Venture invests in
Countries BD Venture invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Medical 2 (33%)
- Health Care 2 (33%)
- Biotechnology 2 (33%)
- SaaS 1 (17%)
- EdTech 1 (17%)
Stage
- Funding Round 2 (33%)
- Seed 1 (17%)
- Pre-Seed 1 (17%)
- Series B 1 (17%)
- Venture - Series Unknown 1 (17%)
Country
- Bangladesh 4 (67%)
- United States 2 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Abdul Hafiz Choudhury
Founder
|
Founder | Total investments: 0 | Find email | |
Shawkat Hossain
Managing Director
|
Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AmarSource
|
AmarSource is a R&D company that takes on challenges to solve engineering problems. | Venture - Series Unknown / Jan 31, 2022 | |
E-Desh
|
E-Desh is an E-Commerce Logistics Company that provides integrated logistic solutions with experience, capabilities, functional expertise, technological embedment. | Series B / Dec 28, 2021 | |
Esho Shikhi
|
Eshosikhi.com is an one stop online platform providing students with 360 degree solution.Students of Bangladesh can take preparation on K12 education, university entrance exam and job preparation in this platform. | Pre-Seed / Nov 05, 2019 | |
Beetles Cyber Security
|
Beetles is an ISO 27001 certified offensive cybersecurity consultancy firm. We specialize in a manual and exploitative PenTesting assessments of a company’s IT environment. With a hacker-powered, platform-led approach, we simulate a real-world attack scenario on applications, APIs, network and cloud infrastructure, and network devices. Our ManualPenTests, by skilled and experienced ethical hackers, are smaller, faster, more agile, and easily integrates with any development environment and process. While our PenTest_as_a_Service (PTaaS) ensures continuous coverage of the scope through a properly defined, structured approach and collaboration with your internal team. | $237.9K / Seed / Mar 13, 2019 | |
RenaMed Biologics
|
RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function. The company focuses on patients suffering from acute renal failure and additional indications where kidney function is compromised. It develops RBI-01, which utilizesphysiologically active human renal epithelial cells and administered ex vivo, to replace and maintain severely compromised, or lost kidney functions due to illness, or trauma. The company was founded in 1995 as Nephros Therapeutics, Inc. and changed its name to RenaMed Biologics, Inc. in 2005. RenaMed Biologics, Inc. is based in Lincoln, Rhode Island. | $40M / Sep 07, 2006 | |
ViaCyte
|
ViaCyte is a preclinical therapeutic company specializing in regenerative medicine therapies for diabetes. Their therapy is based on the differentiation of stem cells into pancreatic beta-cell precursors, with subcutaneous implantation in an encapsulation device. Data in their publications demonstrate that these cells can produce therapeuticallyrelevant levels of insulin in response to blood glucose, and sustain diabetic animals. Their goal is a product which can free both Type 1 and Type 2 patients with diabetes from insulin dependence on a long-term basis, while reducing or eliminating hypoglycemic, microvasculature, and weight-related cardiovascular complications. | $20M / May 03, 2006 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does BD Venture invest in?
BD Venture invests primarily in Medical, Health Care and Biotechnology startups, most often at Funding Round and Seed stage. Most of the 6 investments tracked by Shizune back companies in Bangladesh. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BD Venture?
Public channels for BD Venture include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BD Venture?
The team at BD Venture includes Abdul Hafiz Choudhury (Founder) and Shawkat Hossain (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
